Search Results - "Fagerstrom, K. O"

Niccine®, a Nicotine Vaccine, for Relapse Prevention: A Phase II, Randomized, Placebo-Controlled, Multicenter Clinical Trial by Tonstad, Serena, Heggen, Eli, Giljam, Hans, Lagerbäck, Per-Åke, Tønnesen, Philip, Wikingsson, Lena Degling, Lindblom, Nina, de Villiers, Sabina, Svensson, Torgny H., Fagerström, Karl-Olov

“…A nicotine vaccine could prevent relapse to smoking by hindering blood nicotine from reaching the brain. Niccine® is a nicotine hapten tetanus-toxoid conjugate…”
Get full text

Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy by Tonnesen, P, Carrozzi, L, Fagerstrom, K. O, Gratziou, C, Jimenez-Ruiz, C, Nardini, S, Viegi, G, Lazzaro, C, Campell, I. A, Dagli, E, West, R

“…Smoking cessation is the one of the most important ways to improve the prognosis of patients with respiratory disease. The Task Force on guidelines for smoking…”
Get full text

Pharmacological treatments for tobacco dependence by Fagerstrom, K. O, Jimenez-Ruiz, C. A

“…* Smoker's Information Centre and Fagerstrom Consulting, Helsingborg, Sweden, # Smoker's Clinic, General Direction of Primary Care, Community of Madrid,…”
Get full text

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire by Heatherton, T F, Kozlowski, L T, Frecker, R C, Fagerström, K O

“…We examine and refine the Fagerström Tolerance Questionnaire (FTQ: Fagerström, 1978). The relation between each FTQ item and biochemical measures of heaviness…”
Get more information

Clinical pharmacokinetics of nasal nicotine delivery : A review and comparison to other nicotine systems by SCHNEIDER, N. G, LUNELL, E, OLMSTEAD, R. E, FAGERSTRÖM, K.-O

“…Rapid drug delivery (arterial "boli') and high drug concentrations occur with nicotine inhaled in smoke. These are believed to be key elements in producing…”
Get full text

Nicotine replacement: a new approach to reducing tobacco-related harm by Jimenez-Ruiz, C, Kunze, M, Fagerstrom, KO

“…Primary prevention is usually regarded as the most desirable goal in efforts to control tobacco-related diseases. However, this has not been very effective so…”
Get full text

Measuring nicotine dependence: a review of the Fagerstrom tolerance questionnaire by FAGERSTROM, K.-O, SCHNEIDER, N. G

“…In the last decade, the importance of nicotine in maintaining smoking and in cessation difficulty has been acknowledged. Consequently, this has led to efforts…”
Get full text

Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit by Fagerström, Karl O, Hughes, John R, Rasmussen, Thomas, Callas, Peter W

“…OBJECTIVE To monitor the effect of a novel nicotine delivery device that may produce fewer carcinogens (Eclipse) on cigarette smoking, carbon monoxide and…”
Get full text

Effect of nicotine vapour inhalation of the relief of tobacco withdrawal symptoms by LUNELL, E, MOLANDER, L, LEISCHOW, S. J, FAGERSTRÖM, K.-O

“…Fifteen subjects participated in a randomised, placebo-controlled cross-over study to assess the effect of a nicotine vapour inhaler on craving and other…”
Get full text

An alternative tobacco control system by Fagerström, K O

Get more information

Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker? by Fagerström, K O, Tejding, R, Westin, A, Lunell, E

“…OBJECTIVE: To assess the effect of the various nicotine replacement therapies (NRT) on smoking reduction. DESIGN: During an initial sampling week, the subjects…”
Get full text

Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders by Balfour, David J.K., Fagerström, Karl O.

“…During the last decade, nicotine has been used increasingly as an aid to smoking cessation and has been found to be a safe and efficacious treatment for the…”
Get full text

Nicotine addiction and its assessment by Fagerstrom, K O, Heatherton, T F, Kozlowski, L T

Get more information

Swedish Match Company, Swedish snus and public health: a harm reduction experiment in progress? by HENNINGFIELD, JACK E, FAGERSTROM, KARL O

Get full text

Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms by FAGERSTRÖM, K. O, SCHNEIDER, N. G, LUNELL, E

“…Nicotine gum and transdermal nicotine have been shown to relieve withdrawal and double success rates over placebo in trials of smoking cessation. This study…”
Get full text

Cessation of long-term nicotine gum use--a prospective, randomized trial by Hurt, R D, Offord, K P, Lauger, G G, Marusić, Z, Fagerström, K O, Enright, P L, Scanlon, P D

“…Nicotine gum is an important adjunct for smoking cessation for many smokers, and long-term use of nicotine gum will occur in a small percentage of patients. To…”
Get more information

Combination nicotine replacement therapy for smoking cessation: Rationale, efficacy and tolerability by SWEENEY, Christine T, FANT, Reginald V, FAGERSTROM, Karl O, MCGOVERN, Joseph F, HENNINGFIELD, Jack E

“…Currently available nicotine replacement therapy (NRT) medications provide effective treatment for tobacco dependence, typically doubling success rates…”
Get full text

Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program by Herrera, N, Franco, R, Herrera, L, Partidas, A, Rolando, R, Fagerström, K O

“…The effectiveness of nicotine gum in combination with a behavior modification program was studied. The nicotine dependence of participating smokers (N = 322)…”
Get more information

Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers by Fagerström, K O, Kunze, M, Schoberberger, R, Breslau, N, Hughes, J R, Hurt, R D, Puska, P, Ramström, L, Zatoński, W

“…OBJECTIVES: To collect available international data on nicotine dependence as defined by the Fagerström Test of Nicotine Dependence, and to compare levels of…”
Get full text

Effects of smoking cessation on insulin and cardiovascular risk factors--a controlled study of 4 months' duration by Nilsson, P, Lundgren, H, Söderström, M, Fagerström, K O, Nilsson-Ehle, P

“…To investigate the effects on serum lipids, plasma fibrinogen, plasma insulin, plasma C-peptide and blood glucose, of smoking cessation after 4 months. To…”
Get more information